Challenges And Opportunities In Overcoming EGFR TKI Resistance In NSCLC

in #mrmed • last year

Non-small cell lung cancer is a slower-growing variant that can be managed through various approaches, such as radiation therapy, surgery, chemotherapy, and targeted therapy. The tyrosine kinase inhibitors (TKIs) resistance of the epidermal growth factor receptor (EGFR) in advanced mutant non-small cell lung cancer (NSCLC) has a therapeutic challenge.

#mrmedpharmacy #egfrmutations #lungcancer #nsclc #tagrisso80
last year in #mrmed by
$0.00
    Reply 0